BetterLife Pharma prices US$100 million public offering of shares and pre-funded warrants
BetterLife Pharma Inc. announced pricing of a US$100 million public offering of common shares and pre-funded warrants.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.